NPI: 1346608809 · LAWTON, OK 73505 · Urgent Care Clinic/Center · NPI assigned 01/29/2016
Authorized official ASAY, GRANT controls 20+ related entities in our dataset. Read more
| Authorized Official | ASAY, GRANT (CEO) |
| NPI Enumeration Date | 01/29/2016 |
Other providers sharing the same authorized official: ASAY, GRANT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 683 | $30K |
| 2019 | 27,961 | $2.11M |
| 2020 | 46,418 | $3.22M |
| 2021 | 104,505 | $6.83M |
| 2022 | 137,291 | $7.14M |
| 2023 | 132,146 | $4.52M |
| 2024 | 106,286 | $3.64M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68,833 | 66,742 | $6.46M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 98,332 | 96,059 | $4.00M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 47,601 | 46,640 | $3.80M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 27,052 | 26,689 | $3.47M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32,892 | 31,857 | $2.19M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 54,572 | 53,625 | $1.92M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 54,388 | 53,333 | $1.57M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 108,672 | 107,108 | $1.49M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17,987 | 17,656 | $1.46M |
| 87400 | 14,928 | 14,728 | $366K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11,999 | 11,765 | $364K |
| 87807 | 11,513 | 11,328 | $133K | |
| 87428 | 1,430 | 1,408 | $92K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,211 | 1,185 | $61K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 668 | 655 | $42K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 800 | 788 | $41K |
| 87420 | 825 | 817 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 247 | 240 | $10K |
| 71046 | Radiologic examination, chest; 2 views | 193 | 189 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 184 | 177 | $3K |
| 81025 | 318 | 314 | $2K | |
| 73630 | 43 | 43 | $1K | |
| 99201 | 37 | 37 | $1K | |
| 73610 | 30 | 30 | $872.06 | |
| 73130 | 28 | 26 | $839.44 | |
| 81003 | 454 | 448 | $820.31 | |
| 73110 | 16 | 16 | $552.96 | |
| 87299 | 12 | 12 | $118.10 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 13 | 13 | $26.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 12 | 12 | $15.84 |